Evidence map›Paper›PMID 20209607›Full record

ReviewHepatology (Baltimore, Md.)2010

Portal fibroblasts: Underappreciated mediators of biliary fibrosis.

Jonathan A Dranoff, Rebecca G Wells

Open access · bronzeAbstract readReview
In one paragraph

Review in Hepatology (Baltimore, Md.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 139 papers.

0numbers the graph read from it
0cells of the map it votes in
139citing papers in PubMed
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

139 citing papers in PubMed, 267 citations in OpenAlex.

  1. Biliary atresia-related liver fibrosis.Frontiers in cell and developmental biology · 2026
    Review
  2. Article
  3. Article
  4. Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  5. Review
  6. The role of mesenchymal cells in cholangiocarcinoma.Disease models & mechanisms · 2024
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Coffee, adenosine, and the liver.Purinergic signalling · 2024
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma.Cellular and molecular gastroenterology and hepatology · 2023
    Review
  20. Review

79 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Jonathan A DranoffSection of Digestive Diseases, Department of Medicine, Yale University School of Medicine, New Haven, CT, USA. jonathan.dranoff@yale.edu
Rebecca G Wells
University of Pennsylvania · USYale University · US

Funding

Yale Liver CenterP30DK034989 · NIDDK · YALE UNIVERSITY · PI YASUKO IWAKIRI · 1986 to 2026
$31.1M
TGF-B Mediated Fibrosis in a Hepatic Stellate Cell ModelR01DK058123 · NIDDK · YALE UNIVERSITY · PI WELLS, REBECCA G · 2001 to 2016
$4.5M
Regulation of Bile Ductular ProliferationR01DK070849 · NIDDK · YALE UNIVERSITY · PI DRANOFF, JONATHAN A · 2005 to 2009
$1.6M
NIDDK NIH HHS DK34989NIDDK NIH HHS P30 DK034989NIDDK NIH HHS R01 DK058123NIDDK NIH HHS R01 DK070849NIDDK NIH HHS R01 DK58123
6 · The paper itself

Abstract

unlabelledPortal fibroblasts are an important yet often overlooked nonparenchymal cell population in the liver. They are distinct from hepatic stellate cells, yet like stellate cells differentiate in the setting of chronic injury to fibrogenic myofibroblasts, playing an important role in collagen production in the fibrotic liver. Portal fibroblasts (PFs) are located adjacent to bile duct epithelia and thus play a particularly significant role in biliary fibrosis. New data suggest that they may also have key functions independent of fibrogenesis. This review addresses the definition and characteristics of PFs as well as their signaling pathways, interactions with the biliary epithelium, and contributions to liver pathobiology.

conclusionPFs are an important and multifunctional nonparenchymal cell population in need of further study.

Indexed as

AnimalsCell CommunicationCell DifferentiationFibroblastsHumansLiver Cirrhosis, BiliaryPortal SystemSignal Transduction

Identifiers

PMID20209607
PMCPMC2850946
OpenAlexW2012962601

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.